DEC 24, 2015 12:51 PM PST

New Drug Combats Mold Disease

WRITTEN BY: Kerry Evans
People suffering from leukemia or lymphoma are particularly vulnerable to mold diseases such as aspergillosis and mucormycosis.  The drug voriconazole is often used to treat these infections, but causes serious side effects such as kidney and liver damage.  Recently, researchers at the University of California, Davis, confirmed that the drug isavuconazole is just as effective as voriconazole, while causing far fewer side effects.
 
Aspergillus causes serious infections in the immunocompromised.

According to study author George Thompson, “molds are ubiquitous in the environment, but they are generally no consequence for people with intact immune systems … however, for leukemia and lymphoma patients, and others with compromised immune systems, some molds can be 90% fatal”.  

Aspergillosis is caused by mold in the genus Aspergillus.  The mold spores enter the lungs where they can grow into a “fungus ball”.  In the immunocompromised, the spores make their way into the bloodstream where the mold can infect the heart and kidneys.  Mucormycosis, on the other hand, is a disease caused by mold from the order Mucorales where hyphae grow in and around blood vessels. These molds typically infect the sinuses and brain, but can also spread to the gastrointestinal tract.  

In the UC Davis study, 35% of infections responded to isavuconazole, and 36.4% responded to voriconazole.  However, only 42.4% of patients taking isavuconazole reported side effects, compared to 59.8% taking voriconazole.  

Since isavuconazole can treat mold disease with fewer side effects, cancer patients aren’t forced to choose between treating the mold or treating the cancer.  According to Thompson, “when these patients get a bad infection, they still need more chemotherapy … it’s one thing to cure the infection but they end up dying of leukemia.  Now that there’s a drug with fewer side effects, patients can hopefully continue their chemotherapy with fewer interruptions”.

Sources: Futurity, Wikipedia
 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
JAN 09, 2020
Cell & Molecular Biology
JAN 09, 2020
Acidic Stomach Environment May Worsen Microbial Pathogenicity
The acids of the stomach may not pose a problem for bad bugs....
JAN 15, 2020
Microbiology
JAN 15, 2020
Scientists Engineer a New Kind of Life Form
Usig cells harvested from frogs, researchers created tiny robots....
JAN 28, 2020
Technology
JAN 28, 2020
Portable device analyzes microbes in the environment
Aquatic microbes often serve as challenge to study, after all, they are too tiny to detect. But, what if there was a device that can swiftly analyze aquati...
FEB 12, 2020
Drug Discovery & Development
FEB 12, 2020
Does Traditional Chinese Medicine Work Against Coronavirus?
Over 45,000 cases of Wuhan Coronavirus have been reported globally, alongside over 1,100 deaths. Although over 4,700 people are said to have recovered from...
FEB 08, 2020
Drug Discovery & Development
FEB 08, 2020
Drug Targets Brain-Eating Amoebas
Brain-eating amoebas lead to high rates of mortality as a result of encephalitis. In fact, more than 95% of people who develop the infection will die. Unfo...
MAR 30, 2020
Genetics & Genomics
MAR 30, 2020
Scientists Discover an Antibiotic Resistance Gene
The gene enables bacteria to resist the effects of an aminoglycoside antibiotic called plazomycin....
Loading Comments...